{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:01:26Z","timestamp":1761742886868},"reference-count":52,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2006,8]]},"abstract":"<jats:p>Primary hyperparathyroidism is a common disorder of mineral metabolism characterized by incompletely regulated, excessive secretion of parathyroid hormone from one or more of the parathyroid glands. In adults with the disease, a single, benign adenoma is seen approximately 80 percent of the time, with multiple gland involvement comprising most of the remaining patients. Very rarely, a parathyroid cancer is responsible but it is seen in less than 0.5 percent of patients with primary hyperparathyroidism. In this article, we will review important clinical and diagnostic features of asymptomatic primary hyperparathyroidism as well as considerations for surgical or medical management of the disease.<\/jats:p>","DOI":"10.1590\/s0004-27302006000400010","type":"journal-article","created":{"date-parts":[[2006,12,12]],"date-time":"2006-12-12T17:30:21Z","timestamp":1165944621000},"page":"647-656","source":"Crossref","is-referenced-by-count":16,"title":["Asymptomatic primary hyperparathyroidism"],"prefix":"10.1590","volume":"50","author":[{"given":"John P.","family":"Bilezikian","sequence":"first","affiliation":[{"name":"Columbia University, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishaela","family":"Rubin","sequence":"additional","affiliation":[{"name":"Columbia University, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shonni J.","family":"Silverberg","sequence":"additional","affiliation":[{"name":"Columbia University, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","article-title":"A non (1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples","volume":"44","author":"Lepage R","year":"1998","journal-title":"Clin Chem","ISSN":"http:\/\/id.crossref.org\/issn\/0009-9147","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1523-1755.2005.00493.x","article-title":"Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism","volume":"68","author":"D'Amour P","year":"2005","journal-title":"Kidney Int."},{"key":"ref3","first-page":"605","article-title":"Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84","volume":"16","author":"Gao, P","year":"2001","journal-title":"Implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1210\/jc.2002-021266","article-title":"Clinical utility of an immunoradiometric assay for whole PTH (1-84) in primary hyperparathyroidism","volume":"88","author":"Silverberg SJ","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1210\/jc.2002-021404","article-title":"Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone","volume":"88","author":"Maruani G","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","article-title":"\"Incipient\" primary hyperparathyroidism: a \"forme fruste\" of an old disease","volume":"88","author":"Silverberg SJ","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsbmb.2005.06.020","article-title":"The vitamin D requirement in health and disease","volume":"97","author":"Heaney RP","year":"2005","journal-title":"J Steroid Biochem Molec Biol"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg SJ","year":"1989","journal-title":"J Bone Miner Res","ISSN":"http:\/\/id.crossref.org\/issn\/0884-0431","issn-type":"print"},{"key":"ref9","first-page":"4007","article-title":"Vertebral osteopenia: A new indication for surgery in primary hyperparathyroidism","volume":"81","author":"Silverberg SJ","year":"1996","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","article-title":"The histormorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure","volume":"70","author":"Parisien M","year":"1990","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref11","first-page":"1562","article-title":"On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism","volume":"84","author":"Dempster DW","year":"1999","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.7326\/0003-4819-109-12-959","article-title":"Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures","volume":"109","author":"Wilson RJ","year":"1988","journal-title":"Ann Intern Med","ISSN":"http:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2796.1993.tb01017.x","article-title":"The risk of hip fractures in patients with primary hyperparathyroidism: A population-based cohort study with a follow-up of 19 years","volume":"234","author":"Larsson K","year":"1993","journal-title":"J Intern Med","ISSN":"http:\/\/id.crossref.org\/issn\/0954-6820","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: A population-based study","volume":"14","author":"Khosla S","year":"1999","journal-title":"J Bone Miner Res","ISSN":"http:\/\/id.crossref.org\/issn\/0884-0431","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2003-030470","article-title":"Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects","volume":"88","author":"Chen Q","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1210\/jc.2005-2102","article-title":"Effect of primary hyperparathyroidism on volumetric bone mineral density assessed by peripheral quantitative computed tomography in postmenopausal women","volume":"91","author":"Charopoulos I","year":"2006","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1007\/s00198-003-1482-4","article-title":"Bone strength in primary hyperparathyroidism","volume":"14","author":"Bilezikian JP","year":"2003","journal-title":"Osteoporos Int","ISSN":"http:\/\/id.crossref.org\/issn\/0937-941X","issn-type":"print"},{"key":"ref18","first-page":"N117","article-title":"Non-classical target organs in primary hyperparathyroidism","volume":"17","author":"Silverberg SJ","year":"2003","journal-title":"J Bone Min Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-80-2-182","article-title":"The neuromuscular disease of hyperparathyroidism","volume":"80","author":"Patten BM","year":"1974","journal-title":"Ann Intern Med","ISSN":"http:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(94)90128-7","article-title":"Psychologic symptoms before and after parathyroid surgery","volume":"96","author":"Solomon BL","year":"1994","journal-title":"Am J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9343","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1067\/msy.2000.110844","article-title":"Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: Patient description and effects on the SF-36 health survey","volume":"128","author":"Talpos GB","year":"2000","journal-title":"Surgery","ISSN":"http:\/\/id.crossref.org\/issn\/0039-6060","issn-type":"print"},{"key":"ref22","first-page":"211","article-title":"Neurobehavioral symptoms in mild hyperparathyroidism: related to hypercalcemia but not improved by parathyroidectomy","volume":"35","author":"Brown GG","year":"1987","journal-title":"Henry Ford Med J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1210\/jcem.82.1.3666","article-title":"Cardiac abnormalities in patients with PHPT: Implications for follow-up","volume":"82","author":"Stefenelli T","year":"1997","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0002-9343(93)90260-V","article-title":"Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy","volume":"95","author":"Stefenelli T","year":"1993","journal-title":"Am J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9343","issn-type":"print"},{"key":"ref25","first-page":"N117","article-title":"Non-classical target organs in primary hyperparathyroidism","volume":"17","author":"Silverberg SJ","year":"2002","journal-title":"J Bone Miner Res","ISSN":"http:\/\/id.crossref.org\/issn\/0884-0431","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1210\/jcem.85.10.6880","article-title":"Augmentation of central arterial pressure in mild primary hyperparathyroidism","volume":"85","author":"Smith JC","year":"2000","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref27","first-page":"S381","article-title":"Vascular stiffness is increased in patients with primary hyperparathyroidism","volume":"17","author":"Rubin MR","year":"2002","journal-title":"J Bone Mineral Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1995.tb02043.x","article-title":"Vitamin D status in primary hyperparathyroidism in India","volume":"43","author":"Harinarayan DV","year":"1995","journal-title":"Clin Endocrinol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0002-9343(74)90812-2","article-title":"Parathyroid function in vitamin D deficiency in primary hyperparathyroidism","volume":"54","author":"Lumb GA","year":"1974","journal-title":"Am J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9343","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0002-9343(99)00294-6","article-title":"Vitamin D deficiency in primary hyperparathyroidism","volume":"107","author":"Silverberg SJ","year":"1999","journal-title":"Am J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9343","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2004-1772","article-title":"Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency","volume":"90","author":"Grey A","year":"2000","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMcp032200","article-title":"Management of asymptomatic primary hyperparathyroidism","volume":"350","author":"Bilezikian JP","year":"2004","journal-title":"N Eng J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref33","first-page":"S9","article-title":"Consensus development conference statement on primary hyperparathyroidism","volume":"6","year":"1991","journal-title":"J Bone Miner Res","ISSN":"http:\/\/id.crossref.org\/issn\/0884-0431","issn-type":"print"},{"key":"ref34","first-page":"N2","article-title":"Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century","volume":"17","author":"Bilezikian JP","year":"1991","journal-title":"J Bone Min Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1210\/jc.2003-030588","article-title":"How should patients with primary hyperparathyroidism be treated?","volume":"88","author":"Clark OH","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00000658-200009000-00005","article-title":"One hundred consecutive minimally invasive parathyroid explorations","volume":"232","author":"Udelsman R","year":"2000","journal-title":"Ann Surg","ISSN":"http:\/\/id.crossref.org\/issn\/0003-4932","issn-type":"print"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0039-6060(03)00414-8","article-title":"The impact of minimally invasive parathyroidectomy on the way endocrinologists treat primary hyperparathyroidism","volume":"134","author":"Gallagher SF","year":"2000","journal-title":"Surgery","ISSN":"http:\/\/id.crossref.org\/issn\/0039-6060","issn-type":"print"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2265.2004.01984.x","article-title":"Marked and sustained increase in bone density after parathyroidectomy in patients with primary hyperparathyroidism: a six-year longitudinal study with or without parathyroidectomy in a Japanese population","volume":"60","author":"Nomura R","year":"2004","journal-title":"Clin Endocrinol"},{"key":"ref39","first-page":"241","article-title":"The effect of parathyroidectomy on the recurrence of nephrolithiasis","volume":"215","author":"Deaconson TF","year":"1987","journal-title":"Surgery","ISSN":"http:\/\/id.crossref.org\/issn\/0039-6060","issn-type":"print"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.0954-6820.2003.01237.x","article-title":"Parathyroid surgery is associated with a decreased risk of hip and upper arm fractures in primary hyperparathyroidism: a controlled cohort study","volume":"255","author":"Vestergaard P","year":"2004","journal-title":"J Internal Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"Primary hyperparathyroidism: 10-year course with or without parathyroid surgery","volume":"341","author":"Silverberg SJ","year":"1999","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref42","first-page":"103","article-title":"Effects of calcium restriction on metabolic characteristics of premenopausal women","volume":"76","author":"Barger-Lux MJ","year":"1993","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJM198510313131805","article-title":"Sensitivity of the parathyroid hormone-1, 25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism","volume":"313","author":"Insogna KL","year":"1985","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9343(97)00053-3","article-title":"Optimal dietary calcium intake in primary hyperparathyroidism","volume":"102","author":"Locker FG","year":"1997","journal-title":"Am J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9343","issn-type":"print"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2002-020667","article-title":"Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Rubin MA","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1359\/jbmr.2001.16.1.189","article-title":"Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism","volume":"16","author":"Zanchetta JR","year":"2001","journal-title":"J Bone Min Res"},{"key":"ref47","series-title":"Dynamics of Bone and Cartilage Metabolism","volume-title":"Primary hyperparathyroidism","author":"Silverberg SJ","year":"2006"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","article-title":"Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Chow CC","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial","volume":"89","author":"Khan AA","year":"2004","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1586\/17446651.1.2.167","article-title":"Cinacalcet hydrochloride: calcimimetic for the treatment of hyperparathyroidism","volume":"1","author":"Locatelli F","year":"2006","journal-title":"Expert Rev Endocrinol Metab"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1210\/jc.2002-021597","article-title":"The calcimimetic AMG 073 normalizes serum calcium in patients with primary hyperparathyroidism","volume":"88","author":"Shoback DM","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock M","year":"2005","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v50n4\/31866.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T22:10:00Z","timestamp":1707430200000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302006000400010&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0004-27302006000400010"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302006000400010","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}